ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?
about
Mechanisms of Aβ Clearance and Degradation by Glial CellsImplications of GABAergic Neurotransmission in Alzheimer's DiseaseAlzheimer's Disease: Mechanism and Approach to Cell TherapyAβ Clearance, "hub" of Multiple Deficiencies Leading to Alzheimer DiseaseClearance systems in the brain-implications for Alzheimer diseaseThe low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer's diseaseTowards understanding the roles of heparan sulfate proteoglycans in Alzheimer's diseaseSelf-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease PhenotypesIs ApoE ɛ 4 a good biomarker for amyloid pathology in late onset Alzheimer's disease?Towards Personalized Intervention for Alzheimer's DiseaseImmunotherapeutic approaches for Alzheimer's diseaseInnate Immunity Fights Alzheimer's DiseaseOrexin signaling regulates both the hippocampal clock and the circadian oscillation of Alzheimer's disease-risk genesMaximally asymmetric transbilayer distribution of anionic lipids alters the structure and interaction with lipids of an amyloidogenic protein dimer bound to the membrane surfaceOpposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice.Metabolic Profiling and Phenotyping of Central Nervous System Diseases: Metabolites Bring Insights into Brain Dysfunctions.The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: Two sides of the same coin.Retinoic acid isomers facilitate apolipoprotein E production and lipidation in astrocytes through the retinoid X receptor/retinoic acid receptor pathway.Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies.Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-β clearance and aggregation in Alzheimer's disease.The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegenerationHDL and cognition in neurodegenerative disorders.Cholesterol in brain disease: sometimes determinant and frequently implicated.Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement miceAPOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice.Islet adaptation to obesity and insulin resistance in WNIN/GR-Ob rats.Different mechanisms of apolipoprotein E isoform-dependent modulation of prostaglandin E2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microglia.Association of smoking and alcohol drinking with dementia risk among elderly men in ChinaApolipoprotein E Inhibits Cerebrovascular Pericyte Mobility through a RhoA Protein-mediated Pathway.Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE ε4 and Is Detectable over 18-Months.Modeling the Role of the Glymphatic Pathway and Cerebral Blood Vessel Properties in Alzheimer's Disease Pathogenesis.Autoregulated paracellular clearance of amyloid-β across the blood-brain barrierApolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2).Liver X receptor agonist treatment significantly affects phenotype and transcriptome of APOE3 and APOE4 Abca1 haplo-deficient miceNon-alcoholic fatty liver disease induces signs of Alzheimer's disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD modelViscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS)Rescuing effects of RXR agonist bexarotene on aging-related synapse loss depend on neuronal LRP1Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides.The role of APOE in cerebrovascular dysfunction
P2860
Q26741609-68617609-8656-4CC3-B9FD-4A4509A3A5B7Q26768593-4D0411A3-3ECB-47CE-A255-41ED05DB2958Q26778149-93770607-3FD9-46E3-AA56-C643104DDB42Q26779681-2860A98E-B332-4BF2-9C0F-16228913F6A0Q26801541-295F6CC2-3D93-4254-81AD-2FDD1CF42F5CQ26827353-7596DC14-4C6D-4A24-94A8-D270F628C18AQ26992202-05B02D05-5242-49CA-8DEE-8167C1F4F83AQ27324311-0068318C-27C7-4828-B839-8E61DE2134C9Q28069073-F1FFE330-5732-41E6-AD2A-BB6BA875AE03Q28080098-2EDA8A7B-2B63-4EA9-A6B5-27CFA08160CBQ28081278-2B1C6B1A-ACA9-42E1-A29D-E28C8DDE8A61Q28081826-A0F6B63E-640A-46FE-BD60-2E12A7BB3193Q28315261-4F20C6A5-55B2-41C4-AD59-90BB543F61C1Q30384016-49B8F058-D357-46F3-B676-65CB8BA6F36EQ30703354-7421B9CC-2EB3-47BB-929C-6C4FF1354459Q30885784-AC3B7C78-E496-4A36-ADAD-5AC3A30976E5Q30989565-DFFFEEFC-623D-4CAD-9891-931F4A60E223Q33676328-AC0BC557-0246-4F0D-8B88-4D1FEE416949Q33893017-AF014AAB-7CA9-408C-8ECD-D2A72A80073CQ33908201-B2732C6D-BD50-42FE-86DE-7140C91C6218Q34426210-988BD294-F717-45DF-B35A-1E4D00E31112Q34557404-347A95CC-0D92-478D-88B0-6C0AA7DAD3CEQ34614842-B47D6226-CF56-4863-9FF9-BF0F8E1A2671Q34621446-E48D4BA3-D3DB-4DC5-9869-8944E403F263Q35166985-2CB1556E-3AB9-42A9-9273-3DC4884CADB6Q35337169-1173194C-BEC0-41FC-A665-234CBF462AFCQ35430781-25C8C315-1E90-4852-B9A9-2530282AC7BFQ35555134-73D22942-CC10-41F1-AD9C-EB29B89546E6Q35596751-22EF3A07-B125-400F-9530-C9DE312889BAQ35662397-23EBC224-4D00-4839-A634-2FE135FF3E11Q35796631-684EEFBE-7BD5-4B79-958A-FB4A6492DF1CQ35800921-355389B2-9F8E-4067-BAB4-716798A7FFDBQ36174787-23BE2F5F-1555-4868-A9A8-0E17FD40F1AAQ36283527-639D565C-EC8F-43F7-B384-71080B9FC0BDQ36291665-AE50C41E-28D5-433E-BBC1-DEFA9AE62587Q36428502-A608C1AA-6FED-407B-A70C-BA6CB6AEC4D1Q36546334-8F90A649-7502-4102-88FD-729844A68FC8Q36600444-541A41CA-6FAC-41C3-BEA9-2B4FC6473033Q36759501-9CB642E6-3171-4C81-A6A6-310B96AB3758Q36813704-05B27982-CD21-4324-A144-FD0F3240DDBF
P2860
ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?
@en
type
label
ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?
@en
prefLabel
ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?
@en
P2093
P2860
P1433
P1476
ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?
@en
P2093
Takahisa Kanekiyo
P2860
P304
P356
10.1016/J.NEURON.2014.01.045
P407
P577
2014-02-01T00:00:00Z